Associate Professor · University of Sydney & Center to End Corporate Harm
Associate Editor · American Journal of Public Health
Exposing how health harming corporations undermine science & policy — and fighting back. Nick studies the commercial determinants of health, focused on microplastics, toxic chemicals, and ultra-processed foods. He works at the forefront of science translation to drive national and international policy change to protect human health from these products.
Systematic review of microplastic exposure and human health, and translation of that evidence into the UN Global Plastics Treaty negotiations.
Hazard identification, evidence-to-decision frameworks, and reform of US chemical regulation under TSCA — protecting vulnerable populations from environmental chemical exposures.
Lead author of the first systematic study on how industry sponsorship influences nutrition research outcomes — pioneering methods to identify, quantify, and reduce corporate bias in nutrition science.
Publications & media for this topic are being curated. Check back soon, or get in touch for current work in this area.
Dr Nicholas Chartres is a Senior Research Fellow in the School of Pharmacy, Faculty of Medicine & Health at the University of Sydney, and a collaborator with the Program on Reproductive Health and the Environment (PRHE) at UCSF, where he leads the Center to End Corporate Harm.
He specialises in studying the commercial determinants of health — examining how corporations in the chemicals, fossil fuels, and nutrition industries shape scientific evidence and delay regulation to protect their interests at the expense of public health.
As lead author of the first systematic study on how industry sponsorship influences nutrition research outcomes, Nick has pioneered methods to identify, quantify, and reduce corporate bias in science. His work now spans microplastics, environmental chemicals, and systematic review methodology in environmental health.
Nick works with the WHO/ILO Joint Estimates Working Group on work-related burden of disease, advises on chemical risk assessments at the US EPA, and has contributed to international plastics treaty negotiations. He is a committed science communicator, regularly translating complex research for the public through broadcast media, podcasts, and written journalism.